Tag

treatment-planning

Risk-adapted esophagus sparing reduces dose with low severe esophagitis in lung cancer

Risk-adapted esophagus-sparing radiotherapy maintained target coverage, with grade 3 esophagitis in only 1.25% of high-risk patients.

Bone marrow-sparing planning reduced pelvic marrow dose, but heterogeneous evidence did not confirm a consistent reduction in hematologic toxicity.